Works matching AU Rebordosa, Cristina


Results: 15
    1
    2
    3

    Liver, renal, genitourinary and diabetic ketoacidosis risks among new users of empagliflozin versus dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes: Post‐authorization safety study based on multinational cohorts.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 4, p. 1291, doi. 10.1111/dom.15429
    By:
    • Rebordosa, Cristina;
    • Thomsen, Reimar W.;
    • Tave, Arlene K.;
    • Madsen, Morten;
    • Beachler, Daniel C.;
    • Martinez, David;
    • Garcia‐Esteban, Raquel;
    • Plana, Estel;
    • Tormos, Anita;
    • Farsani, Soulmaz Fazeli;
    • Perez‐Gutthann, Susana;
    • Pladevall‐Vila, Manel
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11

    A Cohort Study to Evaluate the Risk of Hospitalisation for Congestive Heart Failure Associated with the Use of Aclidinium and Other Chronic Obstructive Pulmonary Disease Medications in the UK Clinical Practice Research Datalink.

    Published in:
    International Journal of COPD, 2021, v. 16, p. 1461, doi. 10.2147/COPD.S301624
    By:
    • Rebordosa, Cristina;
    • Plana, Estel;
    • Rubino, Annalisa;
    • Aguado, Jaume;
    • Lei, Alejhandra;
    • Daoud, Sami;
    • Saigi-Morgui, Nuria;
    • Perez-Gutthann, Susana;
    • Rivero-Ferrer, Elena
    Publication type:
    Article
    12
    13

    Characteristics of New Users of Aclidinium Bromide, Aclidinium/Formoterol, and Other COPD Medications in the United Kingdom, Denmark, and Germany.

    Published in:
    Clinical Drug Investigation, 2022, v. 42, n. 4, p. 319, doi. 10.1007/s40261-022-01120-2
    By:
    • Rivero-Ferrer, Elena;
    • Olesen, Morten;
    • Plana, Estel;
    • Aguado, Jaume;
    • Saigí-Morgui, Núria;
    • Rubino, Annalisa;
    • Daoud, Sami Z.;
    • Lei, Alejhandra;
    • Perez-Gutthann, Susana;
    • Schink, Tania;
    • Kristiansen, Nina Sahlertz;
    • Hallas, Jesper;
    • Pottegård, Anton;
    • Rebordosa, Cristina
    Publication type:
    Article
    14

    Risk of Major Cardiovascular and Cerebrovascular Events in Users of Lisdexamfetamine and Other Medications for Attention-Deficit/Hyperactivity Disorder in Denmark and Sweden: A Population-Based Cohort Study.

    Published in:
    Neurology & Therapy, 2022, v. 11, n. 4, p. 1659, doi. 10.1007/s40120-022-00396-y
    By:
    • Forns, Joan;
    • Dudukina, Elena;
    • Hägg, David;
    • Szentkúti, Péter;
    • Gembert, Karin;
    • Plana, Estel;
    • Gilsenan, Alicia;
    • Horváth-Puhó, Erzsébet;
    • Ehrenstein, Vera;
    • Reutfors, Johan;
    • Rebordosa, Cristina
    Publication type:
    Article
    15